In patients infected with COVID-19, the presence of increased levels of serum inflammatory markers including IL-6, CRP, LDH, ferritin, and D-dimers has been associated with an increased risk of progression to more severe forms of the disease. The gene discussed is IL6; the disease is COVID-19.